EFFECTS OF COVID-19 ON CRC SCREENING1,a
References
1 Chen RC, Haynes K, Barron J, et al. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 2021;7(6):878–884.
2 American Cancer Society. Colorectal cancer facts & figures 2020-2022. Atlanta: American Cancer Society; 2020.
3 Issaka RB, Taylor P, Baxi A, et al. Model-based estimation of colorectal cancer screening and outcomes during the COVID-19 pandemic. JAMA Netw Open. 2021;4:e216454.
4 London JW, Fazio-Eynullayeva E, Palchuck MB, et al. Effects of the COVID-19 pandemic on cancer-related patient encounters. JCO Clin Cancer Informatics. 2020;4:657-665.
5 IQVIA Institute for Human Data Science. Shifts in healthcare demand, delivery and care during the COVID-19 era. April 2020. Accessed March 24, 2023. https://www.iqvia.com/insights/the-iqvia-institute/covid-19/shifts-in-healthcare-demand-delivery-and-care-during-the-covid-19-era
6 NCCRT. Reigniting colorectal cancer screening as communities face and respond to the COVID-19 pandemic. June 30, 2020. Accessed November 9, 2020. https://nccrt.org/resource/a-playbook-for-reigniting-colorectal-cancer-screening-as-communities-respond-to-the-covid-19-pandemic/
Footnotes
a The HealthCore Integrated Research Database (HIRD) covers ~60 M people in Medicare Advantage and commercial health plans in geographically diverse regions. The receipt of cancer screening was identified with ICD-10-CM and CRC screening CPT codes. Screening rates were analyzed and compared for each month (2019 vs 2020) and used to calculate the estimated total deficit for the entire US population.
Last Updated: 3/24/2023